Evidence map›Paper›PMID 26507875›Full record

ArticleJournal of neurogastroenterology and motility2016

Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers.

Hironobu Mikami, Norihisa Ishimura, Kousuke Fukazawa, Mayumi Okada, Daisuke Izumi, Shino Shimura, Eiko Okimoto, Masahito Aimi, Shunji Ishihara, Yoshikazu Kinoshita

Open access · diamondAbstract read
In one paragraph

Article in Journal of neurogastroenterology and motility, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Application of the Functional Lumen Imaging Probe to Esophageal Disorders.Current treatment options in gastroenterology · 2017
    Review
  10. Functional Lumen Imaging Probe for the Management of Esophageal Disorders: Expert Review From the Clinical Practice Updates Committee of the AGA Institute.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2017
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hironobu MikamiSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Norihisa IshimuraSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Kousuke FukazawaDepartment of Gastroenterology and Hepatology, Kasai City Hospital, Kasai, Japan.
Mayumi OkadaSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Daisuke IzumiSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Shino ShimuraSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Eiko OkimotoSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Masahito AimiSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Shunji IshiharaSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Yoshikazu KinoshitaSecond Department of Internal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsProkinetic drugs such as metoclopramide are frequently used as second-line therapy for patients with gastroesophageal reflux disease. However, their beneficial effects remain unclear. Esophageal motor activities and compliance of the esophagogastric junction (EGJ) are important for prevention of gastroesophageal reflux. Although metoclopramide has been reported to increase lower esophageal sphincter (LES) pressure, its effects on EGJ compliance have not been evaluated. In the present study, we investigated the effects of metoclopramide on esophageal motor activities and EGJ compliance.

methodsNine healthy male volunteers without abdominal symptoms were enrolled. Peristaltic esophageal contractions and LES pressure were examined using high-resolution esophageal manometry, while EGJ compliance was evaluated with an endoluminal functional lumen-imaging probe. After obtaining baseline values for esophageal motor activities and EGJ compliance, metoclopramide (10 mg) was intravenously administered, then all measurements were repeated at 15 minutes after administration in each subject.

resultsFollowing administration of metoclopramide, mean resting LES pressure was significantly increased as compared with the baseline (13.7 ± 9.2 vs 26.7 ± 8.8 mmHg, P < 0.05). In addition, metoclopramide significantly augmented peristaltic contractions, especially in the distal esophageal segment (P < 0.05). On the other hand, distensibility index did not change after administration (4.5 ± 0.5 vs 4.1 ± 0.5 mm(2)/mmHg), suggesting no significant effect of metoclopramide on EGJ compliance.

conclusionsMetoclopramide augmented esophageal contractions without changing EGJ compliance in healthy adults.

Indexed as

Esophageal sphincterEsophagogastric junctionlowerManometryMetoclopramideMotor Activity

Identifiers

PMID26507875
PMCPMC4699728
OpenAlexW2321019939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.